Loading stock data…
Omada Health, Inc. (OMDA)
$20.53-0.67 (-3.16%)
Market ClosedLast close Jul 24
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Omada Health, Inc. in the Healthcare sector is trading at $20.53 with a market capitalization of $1.0B. Wall Street consensus targets $24.58 (12 analysts), implying a +19.7% move over the next 12 months. The stock is currently 24% below its 52-week high of $26.91, remaining 19.7% above its 200-day moving average. On fundamentals, Piotroski 6/9 shows mixed financial quality, Altman Z in the safe zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +19.7% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Oversold momentum (RSI 28) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $78.05M↑ | $75.85M↑ | $68.03M↑ | $61.37M↑ | $54.96M |
| Gross Profit | $48.69M↓ | $53.66M↑ | $45.07M↑ | $40.31M↑ | $31.90M |
| Operating Income | -$4.78M↓ | $3.28M↑ | -$2.51M↑ | -$4.34M↑ | -$8.40M |
| Net Income | -$2.97M↓ | $5.16M↑ | -$3.18M↑ | -$5.31M↑ | -$9.45M |
Peer Comparison
JNJUNHPFE
Fundamentals
Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to ad...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$1.03B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-2.69%
Volume
Today's trading volume
1.17M
Recent News
IPO Stock Of The Week: This Eli Lilly Partner Soars 118% In Three Months
Omada, an Eli Lilly partner, has soared more than 118% in just a few months, moving up the right side of a new base.
Omada Health, Inc. (OMDA) Is Up 7.18% in One Week: What You Should Know
Does Omada Health, Inc. (OMDA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Omada Health CEO Sean Duffy Sells 17,000 Shares. What Does This Mean for Investors?
Omada Health, a digital care platform for chronic conditions, reported a notable insider sale amid a year of double-digit stock gains.
Omada Health, Inc. (OMDA) Stock Jumps 10.5%: Will It Continue to Soar?
Omada Health, Inc. (OMDA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Three Stocks That May Be Trading Below Estimated Value In May 2026
The United States market has shown robust growth, with a 1.8% increase over the last week and a remarkable 28% rise over the past year, while earnings are projected to grow by 17% annually. In such an environment, identifying stocks that may be trading below their estimated value can offer investors potential opportunities for capitalizing on future growth.